Actis in $48m India healthcare deal
The private equity firm has acquired a ‘significant stake' in Indian pharmaceutical company Symbiotec as it raises its third emerging markets fund.
23 October 2013•2 mins read
The private equity firm has acquired a ‘significant stake' in Indian pharmaceutical company Symbiotec as it raises its third emerging markets fund.
